Status:
COMPLETED
Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
COVID 19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nasal saline irrigations are a safe and commonly used mechanism to treat a variety of sinonasal diseases including sinusitis, rhinitis, and upper respiratory tract infections. When used properly, thes...
Detailed Description
The novel coronavirus known as SARS-CoV-2 and the associated disease process COVID-19 (coronavirus disease 2019) was first seen in late 2019 in Wuhan, China. Over the following months, it quickly spre...
Eligibility Criteria
Inclusion
- Patients testing positive for COVID-19 at Vanderbilt University Medical Center or VUMC-associated testing centers
- Age of 18 years or greater
- Patients must be planning self-quarantine after infection in the greater Nashville area within a 30-mile radius of Vanderbilt University Medical Center
Exclusion
- Requiring hospitalization - only outpatient COVID-19 cases are eligible for the study
- Current use of nasal saline irrigations or other intranasal medications
- Inability to perform saline irrigations/nasal swabs in separate bathroom away from household contacts
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2022
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04347538
Start Date
May 1 2020
End Date
March 16 2022
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderblt University Medical Center
Nashville, Tennessee, United States, 37232